Skip to main content
Clinical Trials/CTRI/2021/06/033946
CTRI/2021/06/033946
Not yet recruiting
Phase 3

Evaluation of association of Parkinsons Disease symptoms with urinary extracellular vesicles

DrDinesh Upadhya0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: G20- Parkinsons disease
Sponsor
DrDinesh Upadhya
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
DrDinesh Upadhya

Eligibility Criteria

Inclusion Criteria

  • Patients will be enrolled from neurology OPD of Kasturba Hospital Manipal.
  • Patients satisfying the UK PD Brain Bank criteria for idiopathic PD will be included after clinical evaluation by a movement disorder specialist.
  • Criteria includes bradykinesia and at least 1 of the following
  • Muscular rigidity; 4\-6Hz resting tremor; postural instability not caused by a primary visual
  • ,vestibular,cerebellar or proprioceptive dysfunction following the exclusion of other causes of Parkinsonism.
  • Additionally, 3 or more features that supported a diagnosis of PD including: a unilateral onset and presence of a resting tremor, a progressive disorder,
  • Persistent asymmetry maximally affecting the side of onset,
  • Excellent response to levodopa and presence of severe levodopa induced chorea.

Exclusion Criteria

  • atypical Parkinsonism, secondary Parkinsonism,
  • h/o repeated Strokes, intake of antipsychotics,mini\-mental state examination score \<24, presence of cerebral tumor or communicating hydrocephalus,negative response to large doses of Levodopa(if malabsorption is excluded,exposure to 1\-methyl4\- phenyl2,3,6tetrahydropyridine(MPTP), patients who refused or were unable to give consent

Outcomes

Primary Outcomes

Not specified

Similar Trials